Atracurium and severe hepatic disease: a case report

[1]  D. R. Cook,et al.  In vitro degradation of atracurium in human plasma. , 1985, British journal of anaesthesia.

[2]  Chapple Dj,et al.  Pharmacological action of breakdown products of atracurium and related substances. , 1983 .

[3]  G. H. Dewar,et al.  Atracurium: conception and inception. , 1983, British journal of anaesthesia.

[4]  J. S. Clark,et al.  Pharmacological action of breakdown products of atracurium and related substances. , 1983, British journal of anaesthesia.

[5]  F. Foldes,et al.  Protein binding of atracurium and other short-acting neuromuscular blocking agents and their interaction with human cholinesterases. , 1983, British journal of anaesthesia.

[6]  H. Nagashima,et al.  Muscular relaxation with atracurium, vecuronium and duador under balanced anaesthesia. , 1983, British journal of anaesthesia.

[7]  R. Katz,et al.  Modification of atracurium blockade by halothane and by suxamethonium. A review of clinical experience. , 1983, British Journal of Anaesthesia.

[8]  M. Whittaker.  Plasma cholinesterase variants and the anaesthetist , 1980, Anaesthesia.

[9]  P. Duvaldestin,et al.  Pancuronium pharmacokinetics in patients with liver cirrhosis. , 1979, British journal of anaesthesia.

[10]  P. Duvaldestin,et al.  PANCURONIUM PHARMACOKINETICS IN PATIENTS WITH LIVER-CIRRHOSIS , 1978 .

[11]  A. Somogyi,et al.  Disposition kinetics of pancuronium bromide in patients with total biliary obstruction. , 1978, British journal of anaesthesia.

[12]  A. Somogyi,et al.  DISPOSITION KINETICS OF PANCURONIUM BROMIDE IN PATIENTS WITH TOTAL BILIARY OBSTRUCTION , 1977 .

[13]  S. Goldring,et al.  Principles and Practice of Medicine , 1871, Chicago Medical Examiner.

[14]  L. Theodorsen,et al.  Sensitivity to gallamine and pancuronium with special reference to serum proteins. , 1971, British journal of anaesthesia.

[15]  L. Theodorsen,et al.  Sensitivity to tubocurarine and alcuronium with special reference to plasma protein pattern. , 1971, Anaesthesia.

[16]  A. Baraka,et al.  Correlation between tubocurarine requirements and plasma protein pattern. , 1968, British journal of anaesthesia.

[17]  S. Dikstein,et al.  The binding of d-tubocurarine chloride to plasma proteins. , 1958, The Journal of pharmacology and experimental therapeutics.

[18]  K. Kaufman.  Serum cholinesterase activity in the normal individual and in people with liver disease. , 1954, Annals of internal medicine.

[19]  J. Dundee,et al.  Resistance to d-tubocurarine chloride in the presence of liver damage. , 1953, The Lancet.

[20]  H. Kunkel,et al.  PLASMA ESTERASE ACTIVITY IN PATIENTS WITH LIVER DISEASE AND THE NEPHROTIC SYNDROME , 1947, The Journal of experimental medicine.

[21]  J. Wilkinson,et al.  The Principles and Practice of Medicine , 1886, Edinburgh Medical Journal.